BNP Paribas Arbitrage SA reduced its position in shares of Maximus, Inc. (NYSE:MMS – Get Rating) by 18.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 71,719 shares of the health services provider’s stock after selling 16,742 shares during the period. BNP Paribas Arbitrage SA owned about 0.12% of Maximus worth $5,714,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of MMS. Moors & Cabot Inc. acquired a new position in shares of Maximus during the third quarter worth $50,000. Exchange Traded Concepts LLC raised its holdings in Maximus by 50.0% in the fourth quarter. Exchange Traded Concepts LLC now owns 765 shares of the health services provider’s stock valued at $61,000 after acquiring an additional 255 shares in the last quarter. Fieldpoint Private Securities LLC raised its holdings in Maximus by 23.0% in the fourth quarter. Fieldpoint Private Securities LLC now owns 840 shares of the health services provider’s stock valued at $67,000 after acquiring an additional 157 shares in the last quarter. Van ECK Associates Corp raised its holdings in Maximus by 10.5% in the fourth quarter. Van ECK Associates Corp now owns 1,465 shares of the health services provider’s stock valued at $117,000 after acquiring an additional 139 shares in the last quarter. Finally, Eagle Bay Advisors LLC raised its holdings in Maximus by 51.4% in the third quarter. Eagle Bay Advisors LLC now owns 1,883 shares of the health services provider’s stock valued at $156,000 after acquiring an additional 639 shares in the last quarter. 93.23% of the stock is currently owned by institutional investors and hedge funds.
MMS stock opened at $64.38 on Friday. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.45 and a quick ratio of 1.45. Maximus, Inc. has a 1-year low of $63.20 and a 1-year high of $94.79. The firm has a fifty day moving average price of $73.66 and a two-hundred day moving average price of $77.08. The firm has a market cap of $3.95 billion, a price-to-earnings ratio of 16.14 and a beta of 0.70.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 31st. Shareholders of record on Friday, May 13th will be paid a dividend of $0.28 per share. The ex-dividend date is Thursday, May 12th. This represents a $1.12 annualized dividend and a yield of 1.74%. Maximus’s payout ratio is 28.07%.
Several analysts recently issued reports on the stock. Zacks Investment Research cut shares of Maximus from a “hold” rating to a “strong sell” rating and set a $57.00 price target on the stock. in a report on Tuesday. StockNews.com assumed coverage on shares of Maximus in a report on Thursday, March 31st. They issued a “hold” rating on the stock.
About Maximus (Get Rating)
Maximus, Inc provides business process services (BPS) to government health and human services programs. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers various BPS solutions, such as program administration, appeals and assessments, and related consulting works for U.S.
- Get a free copy of the StockNews.com research report on Maximus (MMS)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.